Ariz. firm raises funds for study of breast cancer Dx test

04/17/2013 | GenomeWeb Daily News (free registration)

Provista Diagnostics has obtained $6 million in Series A financing, bringing the company's total for that round to $13.5 million. The Scottsdale, Ariz.-based molecular diagnostics firm will use the money in part to conduct prospective clinical studies of its dtectDx Breast system, a breast cancer diagnostic assay that uses protein biomarkers.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX